Search Orphan Drug Designations and Approvals
-
| Generic Name: | SCN2A mRNA knockdown antisense oligonucleotide |
|---|---|
| Date Designated: | 01/05/2021 |
| Orphan Designation: | Treatment of SCN2A Developmental and Epileptic Encephalopathy |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Praxis Precision Medicines, Inc. One Broadway, 16th Floor Cambridge, Massachusetts 02142 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







